期刊文献+

RP-HPLC法测定吲哚美辛巴布膏的含量和有关物质 被引量:2

RP-HPLC determination of indometacin patch and its related substances
原文传递
导出
摘要 目的:建立RP-HPLC法测定吲哚美辛巴布膏的含量和有关物质。方法:采用Agilent ZORBAX Eclipse Plus C18色谱柱(4.6 mm×150 mm,5μm),以甲醇-水-磷酸(600∶400∶1)为流动相,流速1.0 mL·min^-1,检测波长228 nm,柱温40℃。结果:吲哚美辛浓度在0.5~10μg·mL-1及10~200μg·mL-1范围内呈良好线性关系(r=0.9999);方法的平均回收率(n=9)为99.3%,RSD=1.1%;3批样品含量测定结果分别为98.4%、97.1%和98.2%,有关物质检查中吲哚美辛峰与各杂质分离度符合要求。结论:经方法学验证,该方法可用于控制吲哚美辛巴布膏主药及有关物质的含量测定。 Objective: To establish an RP- HPLC method for determination of Indometacin Patch and its related substances. Methods: The column was Agilent ZORBAX Eclipse Plus C18( 4. 6 mm ×150 mm,5 μm). The mobile phase was composed of methanol- water- phosphoric acid( 600∶ 400∶ 1) at a flow rate of 1. 0 mL·min- 1. The detection wavelength was 228 nm and the column temperature was 40 %C. Results: The calibration curves were linear in the ranges of 0. 50- 100 μg·mL- 1and 10. 0- 200. 0 μg·mL- 1. The average recovery( n = 9) was 99. 3%with a RSD of 1. 1%. The content determination results for the 3 batches of samples were 98. 4%,97. 1% and98. 2%,respectively. The resolution between indometacin and its related substances was acceptable. Conclusion:The method is suitable for determination of the content and related substances of indometacin patch according to the methodological verification.
出处 《药物分析杂志》 CAS CSCD 北大核心 2014年第7期1310-1314,共5页 Chinese Journal of Pharmaceutical Analysis
关键词 吲哚美辛巴布膏 反相高效液相色谱法 杂质检测 克罗米通 麝香草酚蓝 对氯苯甲酸 indometacin patch RP-HPLC impurity detection crotamiton thymol blue para-chlorobenzoic acid
  • 相关文献

参考文献7

二级参考文献18

  • 1丁建,朱斌清,王玲娜.RP-HPLC法同时测定颠茄磺苄啶片中SMZ和TMP的含量[J].药物分析杂志,2005,25(6):715-716. 被引量:3
  • 2国家药典委员会编.中华人民共和国卫生部药品标准,中成药方制剂,第十八册[M].,1998.357.
  • 3国家药品监督管理局.《国家药品标准》第十册[M].,2002.288.
  • 4Barry BW.Lipid-protein-partitioning theory of skin penetration enhancement[J].] Controlled Release,1991,15: 237-240.
  • 5Panigrahi L, Pattnaik S, Ghosal SK.Design and characterization of mucoadhesive buccal patches of salbutamol sulphate[J]. Acta Pol Pharm, 2004, 61 (5): 351-360.
  • 6Charoo NA, Anwer A, Kohli K, et al. Transdermal delivery of flurbiprofen: permeation enhancement,design, pharmacokinetic, and pharmacodynamic studies in albino rats[J].Pharm Dev Technol, 2005,10 (3): 343-351.
  • 7Zhao H, Lee CH, Chung SJ, et al.In vitro and in vivo evaluation of a novel nonscrotal matrix-type transdermal delivery system of testosterone[J].Drug Dev Ind Pharm, 2005, 31 (3): 257-261.
  • 8Li GL, de Vries J J, van Steeg T J, et at. Transaermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment[J]. J Control Release, 2005, 101 (1-3); 199-208.
  • 9Denet AR, Vanbever R, Preat V.Skin electroporation for transdermal and topical delivery[J]. Adv Drug Deliv Rev, 2004, 56 (5): 659-674.
  • 10Radbruch L, Eisner F.Ciinical experience with transdermal fentanyl for the treatment of cancer pain in Germany[J].Keio J Med, 2004, 53 (1): 23-29.

共引文献25

同被引文献18

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部